SUCROSOMIAL TECHNOLOGY

A unique delivery system, a revolution in the field of nutraceuticals, which guarantees maximum efficacy in transporting and absorbing essential bioactive compounds.

CETYLATED FATTY ACIDS

A patented solution designed to enhance joint and muscle mobility, known for its exceptional skin penetration and rapid absorption.

PRODUCTS

PharmaNutra products are designed to provide a safe and effective response to health and well-being requirements at any stage of life.
R&D

We are committed to advancing nutraceutical science by developing effective, high-quality supplements and medical devices.

In our laboratories, we use cutting-edge research models to drive innovation, blending solid scientific methods with a forward-thinking approach to technology and patents. PharmaNutra's research focuses on key health areas, especially addressing nutritional deficiencies in minerals and vitamins, supporting muscle and joint health and enhancing functional and sports nutrition.

MORE
THERAPEUTIC AREAS

Our scientific research

NEWS

Inform, innovate, inspire: putting health first

Stay updated with the latest from PharmaNutra: scientific insights, events, groundbreaking products and updates tailored to support your professional practice.
News & Events

Pharmanutra attends the German Spring Conference 2019

Read more
Raw materials

Alesco and Polaris: a new partnership to continue the distribution of Algal DHA

Read more
Iron deficiency

Sucrosomial Iron: further scientific acknowledgments of its value and efficacy

Read more
Iron deficiency

A new technology to counter iron deficiency

Read more
Minerals and vitamins

The benefits of magnesium on sleep

Read more
News & Events

Cetilar Villorba Corse first tests for the 24 Hours of Le Mans 2018

Read more
News & Events

World Partners Convention 2018: a borderless success

Read more
News & Events

PharmaNutra takes part int the Aim Italia Conference 2020

Read more
News & Events

PharmaNutra means high-level sports

Read more
Raw materials

UltraD3®: the first vitamin D3 with Sucrosomial® Technology

Read more
Raw materials

Alesco-PharmaNutra Merger: from July 2024, Alesco will become a business division of the Group

Read more
Raw materials

SiderAL® r.m. Readers’ Ingredient of the Year at the NutraIngredients Awards

Read more
News & Events

Cetilar® at Cariparma Running

Read more
Iron deficiency

PharmaNutra at the NATA Symposium 2019 for the third consecutive year

Read more
Raw materials

Alesco: new trade agreement with Trades SA for Spain and Portugal

Read more